← back to search

Zhao Cui

King University · US
🔎 Find collaborators in Nephrology · Pulmonary and Respiratory Medicine →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Nephrology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Renal Diseases and Glomerulopathies, Vasculitis and related conditions, Cell Adhesion Molecules Research, and Amyloidosis: Diagnosis, Treatment, Outcomes.
h-index
39
citations
4,475
works
206
NIH funding
primary concept
email

Recent publications

Efficacy and Safety of MIL62, a Glycoengineered Type II Anti-CD20 Antibody, in Primary Membranous Nephropathy: A Phase 3, Randomized, Controlled Trial
Journal of the American Society of Nephrology 2025cited by 3position: firstdoi
LBA84 Efficacy and safety of GFH375 monotherapy in previously treated advanced KRAS G12D-mutant pancreatic ductal adenocarcinoma (PDAC)
Annals of Oncology 2025cited by 2position: lastdoi
Association of air pollutants exposure and increased risk of peritoneal dialysis-related peritonitis: An observational study from PDTAP cohort
Peritoneal Dialysis International 2025cited by 1position: middledoi
Development of risk-prediction tool for peritoneal dialysis related peritonitis and external validation in the PDTAP cohort
Chinese Medical Journal 2025cited by 0position: middledoi
A single-domain antibody targeting factor XII inhibits both thrombosis and inflammation
Nature Communications 2024cited by 19position: middledoi
Epidemiology, clinical features, risk factors, and outcomes in anti-glomerular basement membrane disease: A systematic review and meta-analysis
Autoimmunity Reviews 2024cited by 17position: middledoi
Short-chain fatty acids ameliorate experimental anti-glomerular basement membrane disease
Clinical Immunology 2024cited by 17position: middledoi
Association between serum potassium, risk and prognosis of peritonitis in peritoneal dialysis patients - results from the Peritoneal Dialysis Telemedicine-assisted Platform Cohort (PDTAP) Study
Journal of Nephrology 2024cited by 3position: middledoi
Autoantibodies against laminin-521 are pathogenic in anti-glomerular basement membrane disease
Kidney International 2023cited by 17position: middledoi
Evaluation of the Risk Prediction Models in Predicting Kidney Outcomes in Antiglomerular Basement Membrane Disease
Kidney International Reports 2023cited by 8position: middledoi
The Prevalence and Characteristics of Circulating IgA Anti-Glomerular Basement Membrane Autoantibodies in Anti-Glomerular Basement Membrane Disease
Kidney International Reports 2023cited by 4position: middledoi
Complement C3a and C3a Receptor Activation Mediates Podocyte Injuries in the Mechanism of Primary Membranous Nephropathy
Journal of the American Society of Nephrology 2022cited by 90position: middledoi
Autoimmunity in Anti–Glomerular Basement Membrane Disease: A Review of Mechanisms and Prospects for Immunotherapy
American Journal of Kidney Diseases 2022cited by 22position: middledoi
Mapping the T cell epitopes of the M-type transmembrane phospholipase A2 receptor in primary membranous nephropathy
Kidney International 2022cited by 17position: middledoi
Predictors of Kidney Outcomes of Anti-Glomerular Basement Membrane Disease in a Large Chinese Cohort
American Journal of Nephrology 2022cited by 15position: middledoi
Bioinformatics analysis and identification of hub genes and immune-related molecular mechanisms in chronic myeloid leukemia
PeerJ 2022cited by 10position: middledoi
Rituximab for the treatment of refractory anti-glomerular basement membrane disease
Renal Failure 2022cited by 10position: middledoi
Optimal Value for Serum Anti-PLA2R Antibody in Primary Membranous Nephropathy: A Multicenter Observational Study
American Journal of Nephrology 2022cited by 9position: middledoi
Quantitative Proteomic Analysis of Plasma Exosomes to Identify the Candidate Biomarker of Imatinib Resistance in Chronic Myeloid Leukemia Patients
Frontiers in Oncology 2021cited by 33position: middledoi
Rituximab Therapy for Primary Membranous Nephropathy in a Chinese Cohort
Frontiers in Medicine 2021cited by 22position: middledoi
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis
Nature Communications 2020cited by 218position: middledoi
The Complement C3a and C3a Receptor Pathway in Kidney Diseases
Frontiers in Immunology 2020cited by 61position: middledoi
Complement activation profile of patients with primary focal segmental glomerulosclerosis
PLoS ONE 2020cited by 46position: middledoi
Clinical-Pathological Features and Outcome of Atypical Anti-glomerular Basement Membrane Disease in a Large Single Cohort
Frontiers in Immunology 2020cited by 30position: middledoi
Renal leukocyte chemotactic factor 2 (ALECT2)-associated amyloidosis in Chinese patients
Amyloid 2020cited by 27position: middledoi
Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy
Kidney International 2019cited by 85position: middledoi
Complement activation products in the circulation and urine of primary membranous nephropathy
BMC Nephrology 2019cited by 74position: middledoi
Primary glomerular nephropathy among hospitalized patients in a national database in China
Nephrology Dialysis Transplantation 2018cited by 54position: middledoi
Clinical and prognostic significance of glomerular C1q deposits in primary MN
Clinica Chimica Acta 2018cited by 30position: middledoi
The Clinical and Immunologic Features of Patients With Combined Anti-GBM Disease and Castleman Disease
American Journal of Kidney Diseases 2018cited by 10position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ming‐Hui Zhao · Tokyo University of Agriculture and Technology31 papers (2012–2024)Xiaoyu Jia · Henan Medical University14 papers (2013–2024)Zhen Qu · King University8 papers (2013–2020)Gang Liu · Shandong University7 papers (2013–2021)Liqiang Meng · King University7 papers (2016–2021)Fang Wang · Qingdao University6 papers (2013–2021)Yimiao Zhang · Jiangsu University6 papers (2014–2020)Jing Huang · King University5 papers (2013–2020)Huang Kuang · Nanchang University5 papers (2022–2024)Qiu‐hua Gu · King University5 papers (2016–2024)Suxia Wang · Peking University5 papers (2013–2020)Xin Wang · King University4 papers (2017–2021)Xiaojuan Yu · King University4 papers (2020–2023)Pierre Ronco · Inserm4 papers (2017–2022)Shui‐yi Hu · King University4 papers (2013–2018)Gang Liu · Changsha University of Science and Technology3 papers (2014–2017)Jiannan Li · Barnes-Jewish Hospital3 papers (2016–2018)Hanna Dêbiec · University Hospital Heidelberg3 papers (2017–2022)Congrong Shen · Ministry of Education of the People's Republic of China3 papers (2020–2023)Fude Zhou · King University3 papers (2017–2021)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Nephrology · Pulmonary and Respiratory Medicine →